FI863029A - Hydroxi- och alkoxi-pyrimidiner. - Google Patents

Hydroxi- och alkoxi-pyrimidiner. Download PDF

Info

Publication number
FI863029A
FI863029A FI863029A FI863029A FI863029A FI 863029 A FI863029 A FI 863029A FI 863029 A FI863029 A FI 863029A FI 863029 A FI863029 A FI 863029A FI 863029 A FI863029 A FI 863029A
Authority
FI
Finland
Prior art keywords
pyrimidiner
alkoxi
hydroxi
och
och alkoxi
Prior art date
Application number
FI863029A
Other languages
English (en)
Other versions
FI89911B (fi
FI863029A0 (fi
FI89911C (fi
Inventor
John Lawrence Lamattina
Frederick Judson Walker
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI863029A0 publication Critical patent/FI863029A0/fi
Publication of FI863029A publication Critical patent/FI863029A/fi
Publication of FI89911B publication Critical patent/FI89911B/fi
Application granted granted Critical
Publication of FI89911C publication Critical patent/FI89911C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
FI863029A 1985-07-24 1986-07-23 Foerfarande foer framstaellning av terapeutiskt aktiva hydroxi- och alkoxipyrimidiner FI89911C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75819985 1985-07-24
US06/758,199 US4711888A (en) 1985-07-24 1985-07-24 Hydroxy and alkoxy pyrimidines

Publications (4)

Publication Number Publication Date
FI863029A0 FI863029A0 (fi) 1986-07-23
FI863029A true FI863029A (fi) 1987-01-25
FI89911B FI89911B (fi) 1993-08-31
FI89911C FI89911C (fi) 1993-12-10

Family

ID=25050889

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863029A FI89911C (fi) 1985-07-24 1986-07-23 Foerfarande foer framstaellning av terapeutiskt aktiva hydroxi- och alkoxipyrimidiner

Country Status (25)

Country Link
US (1) US4711888A (fi)
EP (1) EP0210044B1 (fi)
JP (1) JPH0647579B2 (fi)
KR (1) KR890001549B1 (fi)
CN (1) CN1006792B (fi)
AU (1) AU569194B2 (fi)
CA (1) CA1265519A (fi)
DD (1) DD248588A5 (fi)
DE (1) DE3673718D1 (fi)
DK (1) DK162986C (fi)
EG (1) EG18181A (fi)
ES (1) ES2000734A6 (fi)
FI (1) FI89911C (fi)
GR (1) GR861917B (fi)
HU (1) HU196764B (fi)
IE (1) IE63404B1 (fi)
IL (1) IL79471A0 (fi)
NO (1) NO173442C (fi)
NZ (1) NZ216951A (fi)
PH (1) PH22484A (fi)
PL (2) PL150617B1 (fi)
PT (1) PT83036B (fi)
SU (1) SU1574171A3 (fi)
YU (1) YU45020B (fi)
ZA (1) ZA865489B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG47583A1 (en) * 1986-01-13 1998-04-17 American Cyanamid Co 4,5,6-Substituted-n- (substituted-phenyl) -2- pyrimidinamines
US4959365A (en) * 1986-10-31 1990-09-25 Pfizer Inc. Topical compositions of lipophilic pharmaceuticals agents
HU199683B (en) * 1987-07-22 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions analgesic, antiphlogistic, antipyretic, antianginic and/or antioxidative activity
HU206203B (en) * 1987-12-02 1992-09-28 Pfizer Process for producing acyl derivatives of hydroxypyrimidines
IL92586A (en) * 1988-12-14 1994-06-24 Pfizer History of 5-hydroxy and 5-methoxy-2-aminopyrimidines as inhibitors of interleukin-1 formation
US5071852A (en) * 1988-12-14 1991-12-10 Pfizer Inc. Derivatives of 5-hydroxy and 5-methoxy 2-amino-pyrimidines as inhibitors of interleukin-1 production
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
JPH06505239A (ja) * 1991-01-31 1994-06-16 ワーナー−ランバート・コンパニー 抗炎症剤として有用な4,6−ジ−第三ブチル−5−ヒドロキシ−1,3−ピリミジンの置換されたヘテロアリール類似体
US5177079A (en) * 1991-01-31 1993-01-05 Warner-Lambert Company 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
US5248682A (en) * 1991-01-31 1993-09-28 Warner-Lambert Company 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
EP0902019A4 (en) * 1996-05-16 2002-03-27 Nissan Chemical Ind Ltd METHOD FOR PRODUCING PYRIMIDINE COMPOUNDS
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
JP4533534B2 (ja) 1998-06-19 2010-09-01 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド グリコーゲンシンターゼキナーゼ3のインヒビター
WO2002000683A2 (en) * 2000-06-23 2002-01-03 Vanderbilt University Novel chain-breaking antioxidants
DE102004054080A1 (de) * 2004-11-09 2006-05-11 Wella Ag Haut- oder Haarbehandlungsmittel mit Schutzeffekt
US9133212B1 (en) 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation
US8367669B2 (en) * 2005-06-15 2013-02-05 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation
JP2008156048A (ja) * 2006-12-22 2008-07-10 Isamu Nakamura 車両用板材キャリア
US8877766B2 (en) 2013-02-15 2014-11-04 Peter F. Kador Neuroprotective multifunctional antioxidants and their monofunctional analogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN153791B (fi) * 1979-03-10 1984-08-18 Soc D Etudes Prod Chimique
US4659363A (en) * 1983-07-25 1987-04-21 Ciba-Geigy Corporation N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
EP0164204A1 (en) * 1984-05-12 1985-12-11 FISONS plc Novel pharmaceutically useful pyrimidines

Also Published As

Publication number Publication date
CN1006792B (zh) 1990-02-14
DK349486A (da) 1987-01-25
YU132186A (en) 1988-04-30
KR890001549B1 (ko) 1989-05-08
CA1265519A (en) 1990-02-06
PT83036B (pt) 1989-01-30
EP0210044A3 (en) 1987-10-21
SU1574171A3 (ru) 1990-06-23
JPS6226276A (ja) 1987-02-04
HU196764B (en) 1989-01-30
IE63404B1 (en) 1995-04-19
IL79471A0 (en) 1986-10-31
DK162986B (da) 1992-01-06
FI89911B (fi) 1993-08-31
NO173442B (no) 1993-09-06
DE3673718D1 (de) 1990-10-04
PL260784A1 (en) 1988-08-18
KR870001173A (ko) 1987-03-11
FI863029A0 (fi) 1986-07-23
NO862956L (no) 1987-01-26
DK162986C (da) 1992-06-01
NO173442C (no) 1993-12-15
PL150617B1 (en) 1990-06-30
ES2000734A6 (es) 1988-03-16
CN86104539A (zh) 1987-01-21
AU569194B2 (en) 1988-01-21
US4711888A (en) 1987-12-08
PT83036A (en) 1986-08-01
FI89911C (fi) 1993-12-10
NZ216951A (en) 1989-06-28
IE861952L (en) 1987-01-24
HUT41745A (en) 1987-05-28
EG18181A (en) 1992-09-30
GR861917B (en) 1986-11-24
ZA865489B (en) 1988-03-30
PH22484A (en) 1988-09-12
NO862956D0 (no) 1986-07-23
DD248588A5 (de) 1987-08-12
AU6044786A (en) 1987-04-30
EP0210044B1 (en) 1990-08-29
PL271856A1 (en) 1988-09-29
PL151571B1 (en) 1990-09-28
DK349486D0 (da) 1986-07-23
JPH0647579B2 (ja) 1994-06-22
EP0210044A2 (en) 1987-01-28
YU45020B (en) 1991-06-30

Similar Documents

Publication Publication Date Title
ATE77088T1 (de) 8-phenylxanthine.
FI861601A (fi) Heterocykliska amidderivat.
FI861830A (fi) Taetningsmaterial.
FI865261A (fi) Smoerjfettkomposition.
FI864371A (fi) Tvaolkomposition.
FI864224A0 (fi) Krossnings- och kompakteringstand.
FI864666A (fi) Kryogenisk- och ultraljudsoperationskniv.
DE3668776D1 (de) Endotubus.
FI863029A0 (fi) Hydroxi- och alkoxi-pyrimidiner.
NO864959D0 (no) Polyolefinpreparater.
FI860745A0 (fi) Dekorationsbelaeggning.
DE3668885D1 (de) Fluorbenzylester.
FI864823A (fi) Mikrovaogsugn.
FI860401A0 (fi) Mjukgoerningskomposition foer tekstiler.
FI881887A (fi) Filteranordning.
FI863242A (fi) Benzimidazolderivat.
FI854939A (fi) Flerskivsraffinator.
FI860909A0 (fi) Heterocykliska foereningar.
NO156224C (no) Roekgranat.
NO865186D0 (no) Smoereolje.
NO863229D0 (no) Gasstoerkeprosess.
FI861606A0 (fi) Vinylcyklopropankarboxyl -syraestrar.
FI851079L (fi) Kausticeringsfoerfarande.
FI852302A0 (fi) Foertjockningsanordning.
FI861265A (fi) Avstaondshaollare foer genomslagspapper.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: PFIZER INC.